These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21134409)

  • 21. [Emergent mania with atypical antipsychotics: review of the literature about one case].
    Ducroix C; Beghelli F; Rousset I; Vacheron MN
    Therapie; 2008; 63(2):153-4. PubMed ID: 18677815
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A washout period needed before switching from a neuroleptic to an amphetamine.
    Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19743579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone.
    Ishitobi M; Hiratani M; Kosaka H; Takahashi T; Mizuno T; Asano M; Murata T; Tomoda A; Wada Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):128-31. PubMed ID: 22245026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.
    Chen CK; Wu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1279-80. PubMed ID: 19563854
    [No Abstract]   [Full Text] [Related]  

  • 27. An update on medication management of behavioral disorders in autism.
    Baribeau DA; Anagnostou E
    Curr Psychiatry Rep; 2014 Mar; 16(3):437. PubMed ID: 24488702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorogenic hyperprolactinemia.
    Hoffer ZS; Roth RL; Mathews M
    Psychosomatics; 2009; 50(4):317-24. PubMed ID: 19687170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy.
    Caykoylu A; Ekinci O; Yilmaz E
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):571-2. PubMed ID: 19302830
    [No Abstract]   [Full Text] [Related]  

  • 30. Improvement in tardive dyskinesia with aripiprazole use.
    Witschy JK; Winter AS
    Can J Psychiatry; 2005 Mar; 50(3):188. PubMed ID: 15830835
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aripiprazole-induced stuttering treated with risperidone].
    Rocha FF
    Braz J Psychiatry; 2009 Dec; 31(4):388. PubMed ID: 20098832
    [No Abstract]   [Full Text] [Related]  

  • 32. Aripiprazole treatment of risperidone-induced hyperprolactinemia.
    Chen JX; Su YA; Wang SL; Bian QT; Liu YH; Wang N; Yang FD; Haile C; Kosten TR; Zhang XY
    J Clin Psychiatry; 2009 Jul; 70(7):1058-9. PubMed ID: 19653986
    [No Abstract]   [Full Text] [Related]  

  • 33. Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial.
    Ghanizadeh A; Haghighi A
    Child Psychiatry Hum Dev; 2014 Oct; 45(5):596-603. PubMed ID: 24343476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aripiprazole-associated dyskinesia.
    Sajbel TA; Cheney EM; DeQuardo JR
    Ann Pharmacother; 2005 Jan; 39(1):200-1. PubMed ID: 15598969
    [No Abstract]   [Full Text] [Related]  

  • 35. Significance of findings in aripiprazole for treatment of psychoses in Alzheimer dementia.
    Tsai AC
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):613; author reply 614. PubMed ID: 18591582
    [No Abstract]   [Full Text] [Related]  

  • 36. Aripiprazole for the treatment of irritability associated with autism.
    Farmer CA; Aman MG
    Expert Opin Pharmacother; 2011 Mar; 12(4):635-40. PubMed ID: 21294670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole-induced obsessive-compulsive disorder: a report of 2 cases.
    Desarkar P; Das A; Nizamie SH
    J Clin Psychopharmacol; 2007 Jun; 27(3):305-6. PubMed ID: 17502782
    [No Abstract]   [Full Text] [Related]  

  • 38. A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.
    Ghanizadeh A; Sahraeizadeh A; Berk M
    Child Psychiatry Hum Dev; 2014; 45(2):185-92. PubMed ID: 23801256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study).
    de Boer MK; Wiersma D; Bous J; Sytema S; van der Moolen AE; Wilffert B; Hamamura T; Knegtering H
    J Clin Psychopharmacol; 2011 Aug; 31(4):523-5. PubMed ID: 21720224
    [No Abstract]   [Full Text] [Related]  

  • 40. Reversible Pisa syndrome associated with switching from haloperidol to aripiprazole during lithium treatment.
    Huang YC; Lee Y; Lin PY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1284-5. PubMed ID: 19635518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.